Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Gα t12 Inhibitors

Gα t12 inhibitors belong to a class of chemical compounds that specifically target the Gα t12 subunit of heterotrimeric G proteins. Gα t12 is part of the G12 family, which also includes Gα t13, and plays a significant role in transmitting signals from G-protein-coupled receptors (GPCRs) to downstream effectors involved in various cellular processes. These signals regulate cytoskeletal reorganization, cell migration, and growth. By inhibiting Gα t12 activity, these compounds can modulate pathways linked to Rho family GTPases, which are important in processes such as cell shape changes and movement. Gα t12 inhibitors function by binding to the Gα t12 subunit, preventing its activation or interaction with effector proteins like RhoGEFs, thus blocking the transmission of signals that would normally promote actin reorganization or other cellular activities.

In addition to modulating the actin cytoskeleton and related cell functions, Gα t12 inhibitors have been shown to affect various signaling pathways beyond those directly involving Rho GTPases. Gα t12 interacts with other signaling molecules such as Src-family kinases and ion channels, making inhibitors of this subunit useful tools for dissecting complex signaling networks. These inhibitors are often used in experimental systems to study G-protein-mediated signaling events, providing insight into the regulatory mechanisms governing cellular physiology. By selectively targeting Gα t12, researchers can differentiate the roles of Gα t12-mediated pathways from those governed by other G-protein subunits like Gαs or Gαq, leading to a more nuanced understanding of cellular signaling dynamics.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD 98059 may inhibit the MEK1/2 enzymes involved in the ERK signaling pathway, potentially leading to decreased transcriptional activity of genes encoding Gα t12.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY 294002 targets and inhibits PI3K, which could downregulate AKT signaling and subsequently reduce the synthesis of Gα t12 at the translational level.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB 203580 selectively inhibits p38 MAP kinase, potentially leading to a decrease in the expression of Gα t12 by altering the function of downstream transcription factors.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibiting JNK with SP600125 could decrease AP-1 transcription factor activity, potentially resulting in lower levels of Gα t12 expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

By inhibiting mTOR, Rapamycin could result in a global decrease in cap-dependent translation, including the translation of mRNA encoding Gα t12.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin's inhibition of PI3K could lead to a reduction in the phosphorylation and activity of AKT, potentially leading to reduced expression of Gα t12.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126's inhibition of MEK1/2 may lead to a decreased activity of the ERK signaling pathway, which could result in decreased levels of Gα t12 protein synthesis.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A might lead to an increase in acetylated histones, which could result in the suppression of transcriptional activity of genes, including those encoding Gα t12.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine's inhibition of DNA methyltransferase might result in hypomethylation of DNA and reactivation of tumor suppressor genes that could downregulate Gα t12 expression.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

Gefitinib's inhibition of EGFR tyrosine kinase activity could lead to decreased activation of downstream signaling pathways that are necessary for the synthesis of Gα t12.